"We are a Clinical Trial Facility."

During the past decade, GenHarp Clinical Solutions conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "GenHarp Clinical Solutions" #1 collaborator was "Amgen" with 1 trials as a collaborator, "Clinipace Worldwide" with 1 trials as a collaborator, "Novotech (Australia) Pty Limited" with 1 trials as a collaborator and "Sanofi" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "GenHarp Clinical Solutions" are "Covid19" (1 trials) and "Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "GenHarp Clinical Solutions" in a lesser frequency.

Most popular intervention types in "GenHarp Clinical Solutions" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "LYT-100" (1 trials), "Placebo" (1 trials), "RMC-4630" (1 trials) and "Sotorasib" (1 trials). Other intervention names were less common.

The vast majority of trials in "GenHarp Clinical Solutions" are 2 trials for "All" genders.

Currently, there are NaN active trials in "GenHarp Clinical Solutions". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in GenHarp Clinical Solutions, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in GenHarp Clinical Solutions, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".